Cancer patients' and clinicians' opinions on the best time in secondary care to approach patients for recruitment to longitudinal questionnaire-based research

被引:9
作者
Ashley, Laura [1 ]
Jones, Helen [1 ]
Velikova, Galina [1 ]
Wright, Penny [1 ]
机构
[1] Univ Leeds, St Jamess Inst Oncol, Psychosocial Oncol & Clin Practice Res Grp, Leeds LS9 7TF, W Yorkshire, England
关键词
Cancer; Patients' views; Clinicians' views; Research participation; Recruitment; Questionnaires; QUALITY-OF-LIFE; PROSTATE-CANCER; REPORTED OUTCOMES; PRIMARY-HEALTH; EPOCS SYSTEM; PARTICIPATION; SURVIVORS; BARRIERS; TRIALS; EXPERIENCES;
D O I
10.1007/s00520-012-1518-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A priority of the UK National Cancer Survivorship Initiative is to increase collection of patient-reported outcome measures (PROMs) longitudinally post-diagnosis. This study aimed to gather cancer patients' and clinicians' opinions and preferences about the best time, in the secondary care pathway, to approach patients about joining longitudinal observational PROMs-based (LO-PROMs) research. The sample comprised 15 patients with non-metastatic breast, colorectal or prostate cancer, and 15 clinicians including surgeons, oncologists and nurse specialists. Patients and clinicians participated in one face-to-face topic-guided audio-recorded interview. Data were analysed using thematic content analysis. Patients did not want to be approached about LO-PROMs research early in the care pathway, near diagnosis and treatment planning or before any surgery and its results. Patients felt that LO-PROMs research is best introduced from the time people are 'settled' on (post-surgical) treatment regimens, provided they are coping well emotionally and not experiencing significant physical side effects; patients emphasised variability in people's experience of and response to cancer and treatment. Clinicians also advised against approach near diagnosis, although generally recommended initiating recruitment somewhat sooner than patients. Patients expressed strong homogeneous preferences and ideally wanted to be approached about LO-PROMs research when their initial fears and anxiety about cancer treatment and survival had diminished, and they felt some sense of certainty and optimism about the future. As the timeline of clinical events varies, maximising recruitment may mean approaching patients at varied time points post-diagnosis. Further recruitment implications are discussed.
引用
收藏
页码:3365 / 3372
页数:8
相关论文
共 37 条
[1]  
[Anonymous], AUDUBON, DOI DOI 10.1016/j.jpsychores.2007.05.012
[2]   Integrating cancer survivors' experiences into UK cancer registries: design and development of the ePOCS system (electronic Patient-reported Outcomes from Cancer Survivors) [J].
Ashley, L. ;
Jones, H. ;
Thomas, J. ;
Forman, D. ;
Newsham, A. ;
Morris, E. ;
Johnson, O. ;
Velikova, G. ;
Wright, P. .
BRITISH JOURNAL OF CANCER, 2011, 105 :S74-S81
[3]   Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: The electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system [J].
Ashley, Laura ;
Jones, Helen ;
Forman, David ;
Newsham, Alex ;
Brown, Julia ;
Downing, Amy ;
Velikova, Galina ;
Wright, Penny .
BMC MEDICAL INFORMATICS AND DECISION MAKING, 2011, 11
[4]  
Birnie K, 2010, CAN FAM PHYSICIAN, V56, P137
[5]  
Chaplin JM, 1999, HEAD NECK-J SCI SPEC, V21, P531, DOI 10.1002/(SICI)1097-0347(199909)21:6<531::AID-HED6>3.0.CO
[6]  
2-M
[7]   Invisible barriers to clinical trials: The impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials [J].
Dilts, David M. ;
Sandler, Alan B. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4545-4552
[8]  
EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71
[9]   The health and well-being of cancer survivors in the UK: findings from a population-based survey [J].
Elliott, J. ;
Fallows, A. ;
Staetsky, L. ;
Smith, P. W. F. ;
Foster, C. L. ;
Maher, E. J. ;
Corner, J. .
BRITISH JOURNAL OF CANCER, 2011, 105 :S11-S20
[10]  
Fenton L., 2009, Community Oncology, V6, P207, DOI [10.1016/S1548-5315(11)70546-0, DOI 10.1016/S1548-5315(11)70546-0]